Every Batch Released On Time. Every Record Submission-Ready.
Pharmaceutical manufacturers worldwide operate under the most stringent quality requirements. LIMSera provides AI-powered OOS investigation, GMP-compliant batch release workflows, ICH stability management, and multi-market regulatory infrastructure — across FDA, EMA, PMDA, TGA, and national authorities globally.
When Batch Release Depends On Manual Record Assembly, Every Batch Is A Bottleneck.
Pharmaceutical batch release requires a complete, auditable analytical record for every batch — all test results, all system suitability data, all reagent and standard lots, all instrument calibration statuses, and any OOS investigation records. When this information is scattered across paper worksheets, shared drives, separate stability systems, and ERP batch records, assembling the complete dossier for QP review becomes a time-consuming manual exercise that creates manufacturing bottlenecks and expiry date risks.
Regulatory inspections add another dimension of pressure. FDA warning letters and European GMP non-compliance findings frequently cite inadequate out-of-specification investigation documentation, missing audit trails for data corrections, and instability in electronic record management. When 21 CFR Part 11 compliance is implemented as an overlay on top of legacy paper processes rather than embedded in the workflow, the gaps become visible under inspection scrutiny.
LIMSera embeds GMP compliance and AI intelligence into every analytical workflow — building ISO/IEC 17025-compliant batch records as testing proceeds, managing OOS investigations with AI-assisted root cause analysis, and delivering multi-market submission-ready data packages automatically.
Every Phase Of Your Pharmaceutical Quality Control Programme
Pre-configured for raw material testing, in-process controls, finished product release, and ICH stability studies across all dosage forms.
Raw Material & Excipient Testing
Manage incoming material testing for active pharmaceutical ingredients, excipients, packaging components, and primary packaging materials against pharmacopoeial and in-house specifications. LIMSera handles multi-stage sampling plans, reduced testing programs for approved suppliers, compendial and non-compendial method execution, and vendor qualification data management. Certificate of Analysis verification against approved vendor data is automated — discrepancies trigger hold and investigation workflows before material is released to manufacturing. Quarantine management integrates with ERP/SAP warehouse management for physical inventory control.
The Pharmaceutical QC Workflow, End To End
Material Receipt & Sampling
Incoming materials are received against purchase order with vendor CoA. Quarantine status is applied automatically. Sampling instructions are generated based on material type and sampling plan. Sample collection is recorded with collector identity and representative sampling confirmation.
Sampling & Labelling
Samples are weighed, labelled with unique sample IDs, and registered against the material lot. Sub-samples for multiple test disciplines — identification, assay, microbial limits — are generated with parent-to-sub-sample traceability. Retain samples are registered for reference storage.
Analysis
Tests are executed following validated methods with guided procedure steps, reagent and standard lot tracking, and instrument interface data capture. System suitability criteria are verified automatically before sample analysis. Analyst attribution and review sequences are enforced per GMP requirements.
Specification Check
Results are automatically compared to the registered specification. Out-of-specification results trigger Phase I investigation initiation. Out-of-trend results relative to historical batch performance are flagged for QC scientist evaluation before formal OOS investigation.
QA Approval
QC scientists review all test results with full method, reagent, and instrument context. The QA team reviews the complete batch analytical record, evaluates any investigation outcomes, and performs the final batch certification. QP or AP electronic signature is applied for market-specific batch release.
CoA & Release
On QP/QA approval, the Certificate of Analysis and batch release notification are generated automatically. CoA is delivered to the customer portal, logistics system, and regulatory submission package. Batch release status is published to ERP inventory management for product despatch.
Kanban-Style Batch Tracking From Sampling To Release
Everything Your Pharmaceutical QC Laboratory And Quality Team Needs
Specification Management
Registered specification library with version control, change history, and pharmacopoeial cross-reference. In-house and compendial specifications managed in parallel. Specification changes tracked through formal change control with impact assessment on existing batches.
Certificate of Analysis Generation
Automated CoA with batch number, manufacturing date, expiry date, all release test results, specifications, pass/fail status, and QP/QA release statement. Digital signature with 21 CFR Part 11 compliance. CoA delivered to customer portal, logistics system, and regulatory submission package simultaneously.
AI-Powered OOS Investigation
ICH-aligned three-phase out-of-specification investigation with AI-assisted root cause scoring. Phase I laboratory error investigation with retesting authorisation. Phase II manufacturing investigation with AI assignable cause identification. Phase III full process assessment. All phases documented with time-stamped entries, supervisor approvals, and product disposition decision with regulatory-compliant investigation reports.
21 CFR Part 11 Compliance
Electronic records and electronic signatures meeting FDA 21 CFR Part 11 and EU Annex 11 requirements. Audit trail for every data entry, modification, and approval. Signature manifestations with signer identity, date, time, and meaning statement. Records locked against retrospective modification.
Stability Chamber Management
Stability chamber monitoring with temperature and humidity logging integration. Out-of-specification condition alerts with sample impact assessment. Chamber excursion documentation and regulatory notification preparation. Pull schedule management across multiple chambers and locations.
LIMS-ERP Integration
Bidirectional integration with SAP, Oracle, and other ERP systems. Material release status published to ERP inventory management. Batch records received from ERP for IPC work order generation. CoA data shared with logistics systems for dispatch documentation.
Microbiological Testing Management
Environmental monitoring programme management with location-specific alert and action limits. Microbial limit test result management for non-sterile products. Sterility test management with positive result investigation workflows. Water system monitoring with trend analysis for purified water and WFI systems.
Batch Release Tracking
Real-time batch release status dashboards showing every batch in the release pipeline — sampling complete, testing in progress, OOS under investigation, QC review, QA pending, and released. TAT tracking against SLA targets with escalation for at-risk batches.
Change Control Integration
Laboratory change control for method changes, specification updates, equipment qualification, and supplier changes. Impact assessment on existing test methods and ongoing stability studies. Regulatory submission impact evaluation with regional change notification classification.
Annual Product Review Data
APQR data aggregation from all testing records. AI-generated control charts, reject rate analysis, OOS trend reporting, and stability summary tables assembled automatically. AI surfaces emerging quality patterns across batches and products.
Batch Records That Build Themselves. Release That Happens On Time, Every Time.
Pharmaceutical batch release is a process with zero tolerance for shortcuts and no room for missing data. LIMSera assembles the complete analytical batch record automatically as testing progresses — every test result, every analyst attribution, every system suitability result, every reagent and standard lot used, and every instrument calibration status is captured at the point of execution. By the time QA opens the batch for review, the record is complete.
The batch release dashboard gives QA a real-time view of every batch in the release pipeline — which are complete and awaiting review, which have open investigations, and which are approaching despatch deadlines. QP and AP electronic batch certification is performed on the complete record with a single legally compliant electronic signature. CoA generation is instantaneous on approval. The complete cycle from analytical completion to certificate delivery is measured in hours, not days.
Stability Data That Predicts Shelf Life. Investigations That Start Before OOS.
Pharmaceutical stability programmes are long-running, multi-product commitments that must be maintained with precision across years. LIMSera's stability module generates pull schedules automatically from study design, creates work orders at each time point, and tracks completion across all storage conditions. Chamber monitoring with temperature and humidity logging integration ensures any condition excursion is captured with immediate impact assessment on samples currently on storage.
Stability trending is the most powerful capability. LIMSera displays each parameter's trend over time against the preliminary limits and the registered specification. The Arrhenius-based shelf-life calculation model predicts when a parameter will reach its specification limit, providing an early warning of degradation rate concerns. When any parameter trends outside the preliminary limits — even if still within specification — an out-of-trend investigation is opened automatically, enabling corrective action before the OOS event.
Analytical Data Packages That Are Submission-Ready Before The Dossier Deadline.
Regulatory submissions — NDA, ANDA, CTD Module 3, or CDSCO dossier — require comprehensive analytical data packages covering method validation, specification setting, batch analytical data, and stability study results. LIMSera structures all analytical data in submission-ready formats from the point of generation. Method validation data, specification justification tables, batch analytical result summaries, and stability data tables are assembled from structured records rather than manual compilation.
Post-approval change notifications require analytical data packages demonstrating the change has no adverse impact on product quality. LIMSera's change control module tracks the analytical work required for each change category — minor, moderate, or major — and assembles the supporting data package when the testing is complete. APQR reports submitted to regulatory authorities as part of annual reporting obligations are generated automatically from the accumulated batch data for the review period.
GMP Compliance Embedded In Every Analytical Record.
21 CFR Part 11 Audit Trail
Every data entry, modification, deletion, and approval is timestamped, user-attributed, and permanently locked. Records cannot be altered without a traceable, reason-documented amendment workflow preserving original values.
OOS Investigation Records
Three-phase investigation framework with full documentation at each phase. Retesting authorisation, second-analyst verification, investigation conclusions, and product disposition decisions — all in a regulatory-compliant electronic record.
QP / AP Batch Certification
Electronic batch certification with legally compliant 21 CFR Part 11 signatures. QP/AP review of the complete electronic batch analytical record with configurable signing statement per market jurisdiction.
APQR Data Aggregation
Annual Product Quality Review data automatically aggregated from all testing records for the period. Control charts, OOS trend analysis, stability data summaries, and reject rate analysis assembled for regulatory submission.
Designed For Every Role In Your Pharmaceutical Quality Organisation
Guided method execution, system suitability verification, instrument interface data capture, reagent and standard lot tracking, and structured OOS investigation workflow management
Results review with full batch history context, out-of-trend detection, method validation data management, stability trending, and APQR data compilation tools
Batch release dashboard, OOS investigation oversight, change control management, CAPA tracking, and 21 CFR Part 11 audit trail review for regulatory inspection readiness
Integrated batch analytical record review, investigation outcome evaluation, electronic batch certification with legally compliant signature, and market-specific release documentation
Site master file data, analytical method summaries, stability data packages, OOS investigation summaries, and APQR reports assembled for submission to FDA, EMA, and CDSCO
IPC work order integration with BMR system, real-time batch release status, CoA availability notifications, and materials release publishing to ERP for production planning
Frequently Asked Questions
Ready To Modernise Your Pharmaceutical QC Laboratory?
See LIMSera configured for your dosage forms, regulatory markets, and batch release requirements.
A live walkthrough configured for your laboratory. No generic demos.